EUVIMEDObjevte EUVIMED
Video/Audio

Long Non-Coding RNA PVT1 Enhances Glycolysis in Thyroid Carcinoma by Stabilizing HIF-1α and Activating Glycolytic Gene Transcription

Yingrui Su, Liqun Huang, Wenji Xu, Shengyao Wang, Long Xie

Journal of Visualized Experiments · 2025

DOI: 10.3791/69294 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2025. Written by Yingrui Su and 4 co-authors. Institution: Department of Nuclear Medicine, The Second Affiliated Hospital of Fujian Medical University. Major MEDLINE topics: RNA, Long Noncoding, Warburg Effect, Oncologic, Thyroid Neoplasms, Hypoxia-Inducible Factor 1, alpha Subunit. 33 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

As the foremost endocrine system cancer, thyroid carcinoma exhibits an accelerating epidemiological trend across populations. Despite advances in treatment modalities, recurrence and metastasis remain challenges. The long non-coding RNA PVT1 (lncPVT1) has emerged as a conserved oncogenic regulator in multiple cancer types, yet its specific function in TC requires further exploration. Our research focused on examining how lncPVT1 affects glycolysis under both normoxic and hypoxic conditions using TC cell lines TPC-1 and K1. Overexpression of lncPVT1 significantly enhanced glucose consumption and lactate production under hypoxia, corroborating its ability to augment glycolysis. Further, lncPVT1 upregulated key glycolytic genes such as GLUT1, HK1, HK2, and PGK1, and facilitated TC cell proliferation. Mechanistically, lncPVT1 stabilized hypoxia-inducible factor 1α (HIF-1α) by impeding its degradation and leading to its accumulation. This accumulated HIF-1α then bound to specific regulatory sequences that control the expression of genes involved in glycolysis, ultimately activating these genes and boosting glycolytic activity. Our findings demonstrate that lncPVT1 regulates HIF-1α stability and glycolytic gene expression, advancing our understanding of TC metabolism and potentially revealing novel therapeutic targets.

Subjects

MeSH terms (MEDLINE)

RNA, Long NoncodingWarburg Effect, OncologicThyroid NeoplasmsHypoxia-Inducible Factor 1, alpha SubunitGlycolysisCell Line, TumorHumansTranscription, GeneticGene Expression Regulation, NeoplasticProtein StabilityCell ProliferationTumor Hypoxia

Substances

PVT1 long-non-coding RNA, humanRNA, Long NoncodingHIF1A protein, humanHypoxia-Inducible Factor 1, alpha Subunit

Authors and institutions

  • Department of Nuclear Medicine, The Second Affiliated Hospital of Fujian Medical University.
  • Department of Gastroenterology, The Second Affiliated Hospital of Fujian Medical University.
  • Department of Pathology, The Second Affiliated Hospital of Fujian Medical University.
  • Department of Nuclear Medicine, The Second Affiliated Hospital of Fujian Medical University; xielong@fjmu.edu.cn.

Cite

APA

Su, Y., Huang, L., Xu, W., Wang, S., & Xie, L. (2025). Long Non-Coding RNA PVT1 Enhances Glycolysis in Thyroid Carcinoma by Stabilizing HIF-1α and Activating Glycolytic Gene Transcription. Journal of Visualized Experiments. https://doi.org/10.3791/69294

Vancouver

Su Y, Huang L, Xu W, Wang S, Xie L. Long Non-Coding RNA PVT1 Enhances Glycolysis in Thyroid Carcinoma by Stabilizing HIF-1α and Activating Glycolytic Gene Transcription. Journal of Visualized Experiments. 2025. doi:10.3791/69294

BibTeX
@article{Su2025,
  author = {Su, Yingrui and Huang, Liqun and Xu, Wenji and Wang, Shengyao and Xie, Long},
  title = {Long Non-Coding RNA PVT1 Enhances Glycolysis in Thyroid Carcinoma by Stabilizing HIF-1α and Activating Glycolytic Gene Transcription},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/69294}
}
Start for free →